In the affluent Upper East Side of New York, significantly fewer people have diabetes or severe obesity compared to Brooklyn or Queens. Nevertheless, 2.3 percent of the residents there use medications like Wegovy or Ozempic for weight reduction. One person has set a world record with 43 applications. This may just be the beginning. The challenging drug name Mounjaro is already easily pronounced by millions. There could be a compelling explanation for this, as it is a combination preparation. Long-term studies show that in addition to the effects of Wegovy and Ozempic, nine out of ten individuals can expect additional benefits from these substances. Wegovy and Mounjaro are pre-filled pens that are simply injected into the subcutaneous tissue. Ten seconds – and that’s it. However, some people are reluctant to accept the idea of injecting themselves with a thin needle. There is also a solution for them: the active ingredient from Wegovy is available for oral intake in the form of a pill called Rybelsus. All of these medications have been developed to improve a disrupted blood sugar level and reward consumers with a medically significant weight reduction.